Explore the impact of 3D models in drug discovery and how they enhance predictive insights in pre-clinical research.

A new study looking at deadly animal African trypanosomiasis has revealed how the parasite Trypanosoma congolense evades the ...

With this technology, a scientist can quickly see a 3D representation of an antibody’s target, especially the epitope. As a result, the visual display allows for more precision in choosing an ...

Antibody (Ab)-dependent enhancement of infection occurs when preexisting antibodies present in the body from a primary (first) dengue virus (DENV) infection bind to an infecting DENV particle ...

The in-licensed antibody represents what iBio believes to be the first functional inhibitor of Activin E, a challenging, yet genetically validated therapeutic target playing a key role in regulating ...

The model successfully optimized protein sequences across different experimental scenarios, including enzyme catalytic ...

The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal antibody therapies and other drugs with "human-relevant methods," including ...